Menu
Menu

References

  1. Criner, GJ, Sue, R, Wright, S, Dransfield, M, Rivas-Perez, H, Wiese, T & Morrissey, B. A multicenter randomized controlled trial of Zephyr® endobronchial valve treatment in heterogeneous emphysema (LIBERATE). Am J Respir Crit Care Med, 2018; 198(9), 1151-1164.
  2. Emphysema. MedlinePlus. https://medlineplus.gov/emphysema.html. Published May 17, 2018. Accessed June 25, 2018.
  3. Gore et al., How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax, 2000; 55(12), 1000-1006.
  4. Gardiner C, et al., Exploring the care needs of patients with advanced COPD: an overview of the literature. Respiratory Medicine, 2010; 104(2), 159-165.
  5. Vermeire, P, The burden of chronic obstructive pulmonary disease. Respiratory Medicine, 2002; 96, S3-S10.
  6. COPD: Challenging Symptoms, Stigma and Stereotypes Patient Survey Fact Sheet. https://www.emphysema.net/Survey_Fact_Sheet.htm. Accessed Oct. 4 2017.
  7. Kemp, SV, Slebos, DJ, Kirk, A, Kornaszewska, M, Carron, K, Ek, L & Briault, A. A multicenter randomized controlled trial of Zephyr endobronchial valve treatment in heterogeneous emphysema (TRANSFORM). Am J Respir Crit Care Med, 2017;196(12), 1535-1543.
  8. Valipour, A, Slebos, DJ, Herth, F, Darwiche, K, Wagner, M, Ficker, JH, & Eberhardt, R. Endobronchial valve therapy in patients with homogeneous emphysema. Results from the IMPACT study. Am J Respir Crit Care Med, 2016;194(9), 1073-1082, and data on file at Pulmonx.
  9. Klooster, K, Hartman, JE, ten Hacken, NH, Slebos, DJ. One-year follow-up after endobronchial valve treatment in patients with emphysema without collateral ventilation treated in the STELVIO trial. Respir 2017; 93(2), 112-121.